{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T16:35:14Z","timestamp":1792427714191,"version":"4.5.0"},"reference-count":79,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"unspecified","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["10006062"],"award-info":[{"award-number":["10006062"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Open Resp Res"],"accepted":{"date-parts":[[2026,4,30]]},"published-print":{"date-parts":[[2026,6]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Fibrotic interstitial lung diseases (fILDs) encompass a heterogeneous group of disorders characterised by varying degrees of inflammation and\/or fibrosis. The role of bronchoalveolar lavage lymphocytosis (BALL) as a prognostic biomarker and predictor of corticosteroid (CS) response remains uncertain. We investigated whether, in patients with fILD, increased BALL can serve as a marker for CS responsiveness and whether increased BALL may also predict better long-term outcomes following CS therapy compared with patients with lower BALL levels.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic review was conducted. MEDLINE, Embase, Web of Science and Google Scholar were searched up to 4 August 2025. Eligible studies included mainly observational clinical studies evaluating BALL in fILD, with a focus on short-term CS response (&lt;6\u2009months) as well as long-term survival (&gt;6\u2009months) after treatment, including changes in lung function parameters, radiological response and overall and progression-free survival. Study selection, data extraction and quality assessment were performed independently by two reviewers. Disagreements were resolved by consensus.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>30 studies involving a total of 3083\u2009patients were included. Increased BALL was associated with better CS response as reflected by improved lung function and increased survival in fILD subtypes, such as hypersensitivity pneumonitis and non-specific interstitial pneumonia. However, BALL thresholds varied, and study heterogeneity precluded meta-analysis. Most studies showed moderate to high risk of bias.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Increased BALL may predict CS responsiveness and treatment outcome prediction in fILD; however, clinical implementation remains limited due to insufficient evidence, predominantly observational studies, inconsistent BALL thresholds and heterogeneous results across disease entities. Standardisation and prospective validations are needed to better integrate BALL findings into clinical routine.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>PROSPERO registration number<\/jats:title>\n                    <jats:p>CRD420251057631.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjresp-2025-004035","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:10:30Z","timestamp":1780578630000},"page":"e004035","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["BAL lymphocytosis as a predictive marker for drug response and long-term outcome in fibrotic ILD: systematic review"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1426-4544","authenticated-orcid":false,"given":"Philipp","family":"Suter","sequence":"first","affiliation":[{"name":"Department of Pneumology, Allergology and Clinical Immunology, Inselspital, University Hospital Bern, Bern, Switzerland"},{"name":"Unity of Pneumology, Division of Internal Medicine and Specialties, Fribourg Hospital and University of Fribourg, Fribourg, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annina E","family":"Buechi","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Allergology and Clinical Immunology, Inselspital, University Hospital Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zayne Milena","family":"Roa-Diaz","sequence":"additional","affiliation":[{"name":"Medical Library, University Library of Bern, University of Bern, Bern, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Funke-Chambour","sequence":"additional","affiliation":[{"name":"Department of Pneumology, Allergology and Clinical Immunology, Inselspital, University Hospital Bern, Bern, Switzerland"},{"name":"Lung Precision Medicine (LPM), Department for Biomedical Research (DBMR), University of Bern, Bern, Switzerland"},{"name":"Division of Pulmonology, Department of Medicine, Lausanne University Hospital (CHUV) and University of Lausanne, Lausanne, Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"key":"2026060406101468000_13.1.e004035.1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2005230"},{"key":"2026060406101468000_13.1.e004035.2","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00158-2025","article-title":"Update of the international multidisciplinary classification of the interstitial pneumonias: an ERS\/ATS statement","volume":"66","author":"Ryerson","year":"2025","journal-title":"Eur Respir J"},{"key":"2026060406101468000_13.1.e004035.3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202401-0048PP"},{"key":"2026060406101468000_13.1.e004035.4","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0100-2018","article-title":"Fibrosing interstitial lung diseases: knowns and unknowns","volume":"28","author":"Cottin","year":"2019","journal-title":"Eur Respir Rev"},{"key":"2026060406101468000_13.1.e004035.5","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00069509"},{"key":"2026060406101468000_13.1.e004035.6","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201202-0320ST"},{"key":"2026060406101468000_13.1.e004035.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00404-2023"},{"key":"2026060406101468000_13.1.e004035.8","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.chest.2024.07.166","article-title":"BAL Fluid Cellular Analysis and Radiologic Patterns in Patients With Fibrotic Interstitial Lung Disease","volume":"167","author":"Grant-Orser","year":"2025","journal-title":"Chest"},{"key":"2026060406101468000_13.1.e004035.9","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1164\/rccm.202305-0796OC","article-title":"Combination of BAL and Computed Tomography Differentiates Progressive and Non-progressive Fibrotic Lung Diseases","volume":"208","author":"Barnett","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"2026060406101468000_13.1.e004035.10","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00561-2024","article-title":"Corticosteroid therapy in fibrotic interstitial lung disease: a modified Delphi survey","volume":"10","author":"Funke-Chambour","year":"2024","journal-title":"ERJ Open Res"},{"key":"2026060406101468000_13.1.e004035.11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjresp-2023-002008","article-title":"Systemic corticosteroids in fibrotic lung disease: a systematic review and meta-analysis","volume":"10","author":"Pitre","year":"2023","journal-title":"BMJ Open Respir Res"},{"key":"2026060406101468000_13.1.e004035.12","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1002\/art.42861","article-title":"2023 American College of Rheumatology (ACR)\/American College of Chest Physicians (CHEST) Guideline for the Treatment of Interstitial Lung Disease in People with Systemic Autoimmune Rheumatic Diseases","volume":"76","author":"Johnson","year":"2024","journal-title":"Arthritis Rheumatol"},{"key":"2026060406101468000_13.1.e004035.13","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/145.1.3"},{"key":"2026060406101468000_13.1.e004035.14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1113354"},{"key":"2026060406101468000_13.1.e004035.15","doi-asserted-by":"publisher","DOI":"10.1136\/thorax.56.4.279"},{"key":"2026060406101468000_13.1.e004035.16","doi-asserted-by":"crossref","DOI":"10.1186\/2213-0802-2-4","article-title":"Diagnosis and management of interstitial lung disease","volume":"2","author":"Meyer","year":"2014","journal-title":"Transl Respir Med"},{"key":"2026060406101468000_13.1.e004035.17","doi-asserted-by":"crossref","DOI":"10.1186\/s13643-017-0644-y","article-title":"Optimal database combinations for literature searches in systematic reviews: a prospective exploratory study","volume":"6","author":"Bramer","year":"2017","journal-title":"Syst Rev"},{"key":"2026060406101468000_13.1.e004035.18","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1002\/mar.21657","article-title":"Meta\u2010analysis and traditional systematic literature reviews\u2014What, why, when, where, and how?","volume":"39","author":"Paul","year":"2022","journal-title":"Psychology and Marketing"},{"key":"2026060406101468000_13.1.e004035.19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2215\/CJN.01430307","article-title":"Systematic review and meta-analysis: when one study is just not enough","volume":"3","author":"Garg","year":"2008","journal-title":"Clin J Am Soc Nephrol CJASN"},{"key":"2026060406101468000_13.1.e004035.20","doi-asserted-by":"crossref","first-page":"478","DOI":"10.7861\/clinmedicine.1-6-478","article-title":"Uses and abuses of meta-analysis","volume":"1","author":"Egger","year":"2001","journal-title":"Clin Med (Northfield)"},{"key":"2026060406101468000_13.1.e004035.21","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.l6890","article-title":"Synthesis without meta-analysis (SWiM) in systematic reviews: reporting guideline","volume":"368","author":"Campbell","year":"2020","journal-title":"BMJ"},{"key":"2026060406101468000_13.1.e004035.22","doi-asserted-by":"crossref","DOI":"10.1186\/1471-2288-8-8","article-title":"The harvest plot: a method for synthesising evidence about the differential effects of interventions","volume":"8","author":"Ogilvie","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"2026060406101468000_13.1.e004035.23","unstructured":"Wells GA , Shea B , O\u2019Connell D , et al . The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa Hospital Research Institute. Available: https:\/\/www.ohri.ca\/programs\/clinical_epidemiology\/oxford.asp [Accessed 07 Jun 2025]."},{"key":"2026060406101468000_13.1.e004035.24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033509","article-title":"Exposure to endocrine-disrupting chemicals and anthropometric measures of obesity: a systematic review and meta-analysis","volume":"10","author":"Ribeiro","year":"2020","journal-title":"BMJ Open"},{"key":"2026060406101468000_13.1.e004035.25","doi-asserted-by":"publisher","DOI":"10.1136\/thx.35.1.9"},{"key":"2026060406101468000_13.1.e004035.26","doi-asserted-by":"publisher","DOI":"10.1136\/thx.35.5.328"},{"key":"2026060406101468000_13.1.e004035.27","doi-asserted-by":"crossref","first-page":"17534666221089468","DOI":"10.1177\/17534666221089468","article-title":"Clinical characteristics and prognostic factors of fibrotic nonspecific interstitial pneumonia","volume":"16","author":"Cho","year":"2022","journal-title":"Ther Adv Respir Dis"},{"key":"2026060406101468000_13.1.e004035.28","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.3390\/diagnostics12112767","article-title":"Factors Predictive for Immunomodulatory Therapy Response and Survival in Patients with Hypersensitivity Pneumonitis\u2014Retrospective Cohort Analysis","volume":"12","author":"Lewandowska","year":"2022","journal-title":"Diagnostics (Basel)"},{"key":"2026060406101468000_13.1.e004035.29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/rheumatology\/keab586","article-title":"Clinical role of bronchoalveolar lavage in dermatomyositis-associated interstitial lung disease","volume":"61","author":"He","year":"2021","journal-title":"Rheumatology (Sunnyvale)"},{"key":"2026060406101468000_13.1.e004035.30","first-page":"38","article-title":"Bronchoalveolar lavage impact in sarcoidosis: study of 40 cases","volume":"87","author":"Bacha","year":"2009","journal-title":"Tunis Med"},{"key":"2026060406101468000_13.1.e004035.31","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.154.2.8756813"},{"key":"2026060406101468000_13.1.e004035.32","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01983-2019","article-title":"Impact of BAL lymphocytosis and presence of honeycombing on corticosteroid treatment effect in fibrotic hypersensitivity pneumonitis: a retrospective cohort study","volume":"55","author":"De Sadeleer","year":"2020","journal-title":"Eur Respir J"},{"key":"2026060406101468000_13.1.e004035.33","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.99.13613459"},{"key":"2026060406101468000_13.1.e004035.34","first-page":"731","article-title":"Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis","volume":"29","author":"Giacomelli","year":"2002","journal-title":"J Rheumatol"},{"key":"2026060406101468000_13.1.e004035.35","doi-asserted-by":"publisher","DOI":"10.1002\/art.22696"},{"key":"2026060406101468000_13.1.e004035.36","doi-asserted-by":"publisher","DOI":"10.1378\/chest.91.5.698"},{"key":"2026060406101468000_13.1.e004035.37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.4046\/trd.1999.46.5.685","article-title":"Short-Term Efficacy of Steroid and Immunosuppressive Drugs in Patients with Idiopathic Pulmonary Fibrosis and Pre-treatment Factors Associated with Favorable Response","volume":"46","author":"Kang","year":"1999","journal-title":"Tuberc Respir Dis"},{"key":"2026060406101468000_13.1.e004035.38","doi-asserted-by":"publisher","DOI":"10.1378\/chest.96.4.794"},{"key":"2026060406101468000_13.1.e004035.39","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2021.106534"},{"key":"2026060406101468000_13.1.e004035.40","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01933.x"},{"key":"2026060406101468000_13.1.e004035.41","doi-asserted-by":"crossref","first-page":"77","DOI":"10.4046\/trd.2005.59.1.77","article-title":"Clinical Course of Probable Idiopathic Pulmonary Fibrosis","volume":"59","author":"Kyung","year":"2005","journal-title":"Tuberc Respir Dis"},{"key":"2026060406101468000_13.1.e004035.42","first-page":"887","article-title":"A retrospective cohort study of prognostic factors for death in patients with idiopathic pulmonary fibrosis","volume":"33","author":"Li","year":"2010","journal-title":"Chin J Tuberc Respir Dis"},{"key":"2026060406101468000_13.1.e004035.43","first-page":"37","article-title":"Factors affecting prognosis of idiopathic interstitial pneumonia","volume":"50","author":"Matsuo","year":"1996","journal-title":"Acta Med Okayama"},{"key":"2026060406101468000_13.1.e004035.44","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm.150.1.8025739"},{"key":"2026060406101468000_13.1.e004035.45","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.resinv.2016.09.001","article-title":"Factors associated with the relapse of cryptogenic and secondary organizing pneumonia","volume":"55","author":"Onishi","year":"2017","journal-title":"Respir Investig"},{"key":"2026060406101468000_13.1.e004035.46","first-page":"1","article-title":"Cryptogenic fibrosing alveolitis. Relationships of pulmonary physiology and bronchoalveolar lavage to response to treatment and prognosis","volume":"124","author":"Rudd","year":"1981","journal-title":"Am Rev Respir Dis"},{"key":"2026060406101468000_13.1.e004035.47","doi-asserted-by":"publisher","DOI":"10.1164\/ajrccm\/143.4_Pt_1.814"},{"key":"2026060406101468000_13.1.e004035.48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s12890-017-0412-8","article-title":"Impact of lymphocyte differential count > 15% in BALF on the mortality of patients with acute exacerbation of chronic fibrosing idiopathic interstitial pneumonia","volume":"17","author":"Takei","year":"2017","journal-title":"BMC Pulm Med"},{"key":"2026060406101468000_13.1.e004035.49","first-page":"26","article-title":"The value of serial bronchoalveolar lavages in assessing the clinical progress of patients with cryptogenic fibrosing alveolitis","volume":"135","author":"Turner-Warwick","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2026060406101468000_13.1.e004035.50","first-page":"696","article-title":"Idiopathic pulmonary fibrosis. Pretreatment bronchoalveolar lavage cellular constituents and their relationships with lung histopathology and clinical response to therapy","volume":"135","author":"Watters","year":"1987","journal-title":"Am Rev Respir Dis"},{"key":"2026060406101468000_13.1.e004035.51","doi-asserted-by":"crossref","DOI":"10.1186\/s12931-021-01726-8","article-title":"Impact of bronchoalveolar lavage lymphocytosis on the effects of anti-inflammatory therapy in idiopathic non-specific interstitial pneumonia, idiopathic pleuroparenchymal fibroelastosis, and unclassifiable idiopathic interstitial pneumonia","volume":"22","author":"Yamagata","year":"2021","journal-title":"Respir Res"},{"key":"2026060406101468000_13.1.e004035.52","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4046\/trd.1989.36.4.310","article-title":"Idiopathic Pulmonary Fibrosis: Correlations between Bronchoalveolar Cellular Constituents and the Pathologic, Physiologic and Radiographic Features and Response to Treatment","volume":"36","author":"Cho","year":"1989","journal-title":"Tuberc Respir Dis"},{"key":"2026060406101468000_13.1.e004035.53","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.21037\/jtd-20-2596","article-title":"Fractional analysis of bronchoalveolar lavage in systemic sclerosis-associated interstitial lung disease","volume":"13","author":"Kase","year":"2021","journal-title":"J Thorac Dis"},{"key":"2026060406101468000_13.1.e004035.54","doi-asserted-by":"crossref","DOI":"10.3390\/cells13242066","article-title":"Predictive Value of Flow Cytometry Quantification of BAL Lymphocytes and Neutrophils in ILD","volume":"13","author":"Novoa-Bolivar","year":"2024","journal-title":"Cells"},{"key":"2026060406101468000_13.1.e004035.55","doi-asserted-by":"crossref","first-page":"935","DOI":"10.3390\/diagnostics13050935","article-title":"Bronchoalveolar Lavage Cell Count and Lymphocytosis Are the Important Discriminators between Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis","volume":"13","author":"Sobiecka","year":"2023","journal-title":"Diagnostics (Basel)"},{"key":"2026060406101468000_13.1.e004035.56","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1513\/AnnalsATS.202005-420OC","article-title":"Bronchoalveolar Lavage Lymphocytes in the Diagnosis of Hypersensitivity Pneumonitis among Patients with Interstitial Lung Disease","volume":"17","author":"Patolia","year":"2020","journal-title":"Ann Am Thorac Soc"},{"key":"2026060406101468000_13.1.e004035.57","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00206-2020","article-title":"Bronchoalveolar lavage fluid lymphocytosis in chronic hypersensitivity pneumonitis: a systematic review and meta-analysis","volume":"56","author":"Adderley","year":"2020","journal-title":"Eur Respir J"},{"key":"2026060406101468000_13.1.e004035.58","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202202-0399ST"},{"key":"2026060406101468000_13.1.e004035.59","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01077-2024","article-title":"Development and validation of a clinical, CT, genomic classifier and BAL scoring system for diagnosing idiopathic pulmonary fibrosis","volume":"65","author":"Kam","year":"2025","journal-title":"Eur Respir J"},{"key":"2026060406101468000_13.1.e004035.60","doi-asserted-by":"crossref","DOI":"10.1183\/23120541.00405-2023","article-title":"Prognostic factors of progressive fibrotic hypersensitivity pneumonitis: a large, retrospective, multicentre, observational cohort study","volume":"10","author":"Cano-Jim\u00e9nez","year":"2024","journal-title":"ERJ Open Res"},{"key":"2026060406101468000_13.1.e004035.61","doi-asserted-by":"crossref","first-page":"26295","DOI":"10.1038\/s41598-025-12180-7","article-title":"Analysis of the relationship between bronchoalveolar lavage lymphocyte fraction and detailed autoimmune features in patients with idiopathic interstitial pneumonia","volume":"15","author":"Enomoto","year":"2025","journal-title":"Sci Rep"},{"key":"2026060406101468000_13.1.e004035.62","doi-asserted-by":"crossref","first-page":"220","DOI":"10.3343\/alm.2015.35.2.220","article-title":"Clinical Usefulness of Bronchoalveolar Lavage Cellular Analysis and Lymphocyte Subsets in Diffuse Interstitial Lung Diseases","volume":"35","author":"Lee","year":"2015","journal-title":"Ann Lab Med"},{"key":"2026060406101468000_13.1.e004035.63","doi-asserted-by":"crossref","DOI":"10.3390\/biom15040597","article-title":"Diagnostic Utility of Bronchoalveolar Lavage Flow Cytometric Leukocyte Profiling in Interstitial Lung Disease and Infection","volume":"15","author":"Novoa-Bolivar","year":"2025","journal-title":"Biomolecules"},{"key":"2026060406101468000_13.1.e004035.64","doi-asserted-by":"crossref","first-page":"108594","DOI":"10.1016\/j.clim.2020.108594","article-title":"Bronchoalveolar lavage differential cell count on prognostic assessment of patients with stable or acute interstitial lung disease: A retrospective real-life study","volume":"220","author":"Salonen","year":"2020","journal-title":"Clin Immunol"},{"key":"2026060406101468000_13.1.e004035.65","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.11.006"},{"key":"2026060406101468000_13.1.e004035.66","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rmed.2019.02.012","article-title":"Acute exacerbation of interstitial lung disease after procedures","volume":"150","author":"Amundson","year":"2019","journal-title":"Respir Med"},{"key":"2026060406101468000_13.1.e004035.67","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/s12931-022-01978-y","article-title":"Acute exacerbation of rheumatoid arthritis-associated interstitial lung disease: mortality and its prediction model","volume":"23","author":"Hozumi","year":"2022","journal-title":"Respir Res"},{"key":"2026060406101468000_13.1.e004035.68","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0071-2018"},{"key":"2026060406101468000_13.1.e004035.69","doi-asserted-by":"crossref","first-page":"101","DOI":"10.5603\/ARM.a2021.0012","article-title":"Risk factors for acute exacerbation following bronchoalveolar lavage in patients with suspected idiopathic pulmonary fibrosis: A retrospective cohort study","volume":"89","author":"Abe","year":"2021","journal-title":"Adv Respir Med"},{"key":"2026060406101468000_13.1.e004035.70","doi-asserted-by":"crossref","DOI":"10.1148\/ryct.2021200279","article-title":"Practical Imaging Interpretation in Patients Suspected of Having Idiopathic Pulmonary Fibrosis: Official Recommendations from the Radiology Working Group of the Pulmonary Fibrosis Foundation","volume":"3","author":"Hobbs","year":"2021","journal-title":"Radiol Cardiothorac Imaging"},{"key":"2026060406101468000_13.1.e004035.71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/s13075-024-03371-0","article-title":"Correlation of high-resolution computed tomography and immunological bronchoalveolar lavage in interstitial lung disease at the onset of inflammatory rheumatic diseases: implications for diagnosis and therapeutic strategies","volume":"26","author":"Hoffmann","year":"2024","journal-title":"Arthritis Res Ther"},{"key":"2026060406101468000_13.1.e004035.72","doi-asserted-by":"publisher","DOI":"10.1136\/thorax-2024-222636"},{"key":"2026060406101468000_13.1.e004035.73","doi-asserted-by":"crossref","first-page":"00209","DOI":"10.1183\/23120541.00209-2022","article-title":"Effect of nintedanib on acute exacerbations of fibrosing interstitial lung diseases: a national database study in Japan","volume":"8","author":"Urushiyama","year":"2022","journal-title":"ERJ Open Res"},{"key":"2026060406101468000_13.1.e004035.74","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.rmed.2017.03.026","article-title":"Pirfenidone for acute exacerbation of idiopathic pulmonary fibrosis: A retrospective study","volume":"126","author":"Furuya","year":"2017","journal-title":"Respir Med"},{"key":"2026060406101468000_13.1.e004035.75","first-page":"v1","article-title":"Interstitial lung disease guideline: the British Thoracic Society in collaboration with the Thoracic Society of Australia and New Zealand and the Irish Thoracic Society","volume":"63 Suppl 5","author":"Bradley","year":"2008","journal-title":"Thorax"},{"key":"2026060406101468000_13.1.e004035.76","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.03.00037902"},{"key":"2026060406101468000_13.1.e004035.77","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/joim.12973","article-title":"The value of bronchoalveolar lavage for discrimination between healthy and diseased individuals","volume":"287","author":"Frye","year":"2020","journal-title":"J Intern Med"},{"key":"2026060406101468000_13.1.e004035.78","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1152\/jappl.1991.71.5.1688","article-title":"Determinants of bronchoalveolar lavage cellularity in idiopathic pulmonary fibrosis","volume":"71","author":"Schwartz","year":"1991","journal-title":"J Appl Physiol"},{"key":"2026060406101468000_13.1.e004035.79","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.3390\/diagnostics15111386","article-title":"Impact of Storage Conditions on Bronchoalveolar Lavage Fluid Analysis: A Human Study","volume":"15","author":"Shionoya","year":"2025","journal-title":"Diagnostics (Basel)"}],"container-title":["BMJ Open Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjresp-2025-004035","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T13:10:39Z","timestamp":1780578639000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmjopenrespres.bmj.com\/lookup\/doi\/10.1136\/bmjresp-2025-004035"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,6,4]]},"published-print":{"date-parts":[[2026,6]]}},"alternative-id":["10.1136\/bmjresp-2025-004035"],"URL":"https:\/\/doi.org\/10.1136\/bmjresp-2025-004035","relation":{},"ISSN":["2052-4439"],"issn-type":[{"value":"2052-4439","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6]]}}}